- Home
- BRNS
as 10-24-2025 3:56pm EST
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
| Founded: | 2016 | Country: | United Kingdom |
| Employees: | N/A | City: | GERMANTOWN |
| Market Cap: | 55.9M | IPO Year: | 2021 |
| Target Price: | $3.00 | AVG Volume (30 days): | 253.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.64 - $2.92 | Next Earning Date: | 11-06-2025 |
| Revenue: | $14,969,000 | Revenue Growth: | 1766.46% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Barinthus Biotherapeutics plc News
BRNS Breaking Stock News: Dive into BRNS Ticker-Specific Updates for Smart Investing
ACCESS Newswire
4 months ago
Q2 Virtual Investor Summit: Presentations Available Now
ACCESS Newswire
5 months ago
Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025
Simply Wall St.
5 months ago
Metalpha Technology Holding And 2 Other Promising Penny Stocks
GlobeNewswire
6 months ago
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
Simply Wall St.
6 months ago
Here's Why We're Not Too Worried About Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation
GlobeNewswire
7 months ago
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
ACCESS Newswire
7 months ago
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
ACCESS Newswire
8 months ago
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
Compare BRNS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRNS Barinthus Biotherapeutics plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.